Literature DB >> 6600891

A clinical trial of efficacy of antiproteolytic therapy: can it be done?

B Burrows.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6600891     DOI： 10.1164/arrd.1983.127.2P2.S42

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  6 in total

1.  Long-term performance of a hand held spirometer.

Authors:  A Dirksen; F Madsen; O F Pedersen; A M Vedel; A Kok-Jensen
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

Review 2.  Alpha1-antitrypsin deficiency. 7: Computed tomographic imaging in alpha1-antitrypsin deficiency.

Authors:  S B Shaker; T Stavngaard; J Stolk; B Stoel; A Dirksen
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

Review 3.  Current status of alpha-1-antitrypsin replacement therapy: recommendations for the management of patients with severe hereditary deficiency. Ad Hoc Committee on Alpha-1-Antitrypsin Replacement Therapy of the Standards Committee, Canadian Thoracic Society.

Authors: 
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

4.  Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry.

Authors:  Robert A Stockley; David G Parr; Eeva Piitulainen; Jan Stolk; Berend C Stoel; Asger Dirksen
Journal:  Respir Res       Date:  2010-10-05

5.  Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease.

Authors:  J W Hay; E D Robin
Journal:  Am J Public Health       Date:  1991-04       Impact factor: 9.308

6.  Clinical pharmacokinetics of alpha 1-antitrypsin in homozygous PiZ deficient patients.

Authors:  J Constans; P Carles; A Boneu; J Arnaud; A E Tufenkji; M C Pujazon; C Tavera
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.